F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval
The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.
Full Article
F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval
NYTimes.com
0 shares
1 views
You might like
Related news coverage
FDA Calls for Investigation of the Approval of Biogen’s Alzheimer’s Drug amid Backlash
HNGN
The FDA chief, Janet Woodcock, M.D., has requested for an investigation of Biogen's Alzheimer's drug after recognizing a..
Advertisement
More coverage
-
FDA head calls for inquiry into Alzheimer's drug review
SeattlePI.com
-
FDA head calls for probe into Alzheimer's drug review
SeattlePI.com